| Literature DB >> 28589152 |
Karen Karimi1, Iris Faraklas2, Giavonni Lewis2, Daniel Ha1, Bridget Walker1, Yan Zhai2, Gareth Graves2, Sharmila Dissanaike1.
Abstract
BACKGROUND: There is increasing evidence that sex differences may influence responses after thermal injury and affect clinical outcomes. The objective of this study was to evaluate the relationships between sex, thermal injury, body size, and inpatient mortality in burn patients.Entities:
Keywords: Burn; Gender; Mortality; Outcome; Sex; Survival
Year: 2017 PMID: 28589152 PMCID: PMC5457798 DOI: 10.1186/s41038-017-0083-y
Source DB: PubMed Journal: Burns Trauma ISSN: 2321-3868
Demographics and injury by sex (N = 334)
| Variable |
| Total | Female | Male |
|---|---|---|---|---|
| Age | 0.45 | 43 (30–55) | 45 (33–59) | 43 (30–55) |
| Caucasiana | 0.39 | 271/286 (95%) | 48/50 (96%) | 223/236 (94%) |
| Hispanic/Latinoa | 0.14 | 87/282 (31%) | 11/50 (22%) | 76/232 (33%) |
| Body mass index | 0.31 | 28.2 (24.4–32.4) | 27.8 (23.0–32.9) | 28.3 (24.8–32.4) |
| Body surface area | <0.001 | 2.03 (1.88–2.25) | 1.86 (1.68–2.0) | 2.09(1.92–2.27) |
| At least one comorbidity | 0.13 | 182 (55%) | 38 (63%) | 144 (53%) |
| Diabetes mellitus | 0.10 | 25 (7%) | 8 (13%) | 17 (6%) |
| Current smoker | 0.99 | 78 (23%) | 14 (23%) | 64 (23%) |
| Chronic drinker | <0.05 | 48 (14%) | 3 (5%) | 45 (16%) |
| Drug addict | 0.99 | 28 (8%) | 5 (8%) | 23 (8%) |
| Hypertension requiring medication | 0.72 | 56 (17%) | 11 (18%) | 45 (16%) |
| Mental health diagnosis | 0.18 | 38 (11%) | 10 (17%) | 28 (10%) |
| % TBSA | 0.34 | 33% (25–49%) | 37% (25–60%) | 33% (25–48%) |
| % Full thickness | 0.17 | 19% (4–37%) | 21% (4–47%) | 18% (4–34%) |
| % Partial thickness | 0.26 | 17% (6–26%) | 14% (3–26%) | 17% (7–25%) |
| Full thickness/TBSA ratio | 0.24 | 0.56 (0.41−0.89) | 0.76 (0.18−.94) | 0.55 (0.13−0.88) |
| Inhalation injury | 0.12 | 100 (30%) | 23 (38%) | 77 (28%) |
| Revised Baux | 0.16 | 85 (66−109) | 91 (66−125) | 85 (66−107) |
| Hematocrit | <0.001 | 47 (43–52) | 44 (41–49) | 48 (44–53) |
| Worst base deficit in 1st 24 h | 0.07 | −6.4 (−10.1, −3.4) | −8.3 (−11.6, −4.4) | −6 (−9.9, −3.2) |
| Worst base deficit in 2nd 24 h | 0.82 | −4.7 (−7.3, −2.4) | −4.6 (−7.9, −2) | −4.7 (−7.2, −2.4) |
| BUN | <0.05 | 14 (10–17) | 13 (9–17) | 14 (11–17) |
| Admission blood glucose | 0.55 | 137 (113–179) | 142 (117–186) | 135 (112–178) |
| Admit HgA1c | 0.58 | 5.5 (5.3–6.2) | 5.8 (5.3–6.5) | 5.5 (5.3–6.2) |
| Admit albumin | 0.05 | 3.2 (2.5–3.6) | 2.9 (2.4–3.3) | 3.3 (2.5–3.7) |
| SOFA in 1st 24 h | 0.80 | 6 (2–8) | 6 (2–8) | 6 (3–8) |
| SOFA in 1st 24–48 h | 0.70 | 6 (2–8) | 3 (1–7) | 3 (1–5) |
TBSA total body surface area, BUN blood urea nitrogen, SOFA sequential organ failure assessment
Values reported as median (interquartile range) or n (%) unless otherwise stated; P values: comparing sites using Rank-sum test for continuous or chi-squared or Fisher’s exact for nominal or categorical variables
aUnknown were excluded
Intervention and outcomes by sex (N = 334)
| Variable |
| Total | Female | Male |
|---|---|---|---|---|
| Days from admit to 1st operation | 0.42 | 3 (1–5) | 3 (1–7) | 3 (1–5) |
| Operation total | 0.66 | 3 (1–6) | 2 (16) | 3 (1–16) |
| Postoperative complication | 0.76 | 133 (40%) | 22 (37%) | 111 (41%) |
| Requiring autograft | 0.08 | 241 (72%) | 38 (63%) | 203 (74%) |
| Autograft complication | 1.00 | 53 (16%) | 8 (13%) | 45 (16%) |
| Requiring homograft | 0.28 | 62 (19%) | 8 (13%) | 54 (20%) |
| Homograft complication | <0.05 | 23 (7%) | 6 (10%) | 17 (6%) |
| Integra | 0.53 | 43 (13%) | 6 (10%) | 37 (14%) |
| Integra complication | 0.66 | 16 (5%) | 3 (5%) | 13 (5%) |
| Patients requiring intubation | 0.86 | 258 (77%) | 47 (78%) | 211 (77%) |
| Ventilator days | 0.73 | 3 (1–14) | 3 (1–11) | 3 (1–15) |
| Length of stay | 0.61 | 28 (18–45) | 27 (18–48) | 28 (18–43) |
| Length of stay per TBSAa | 0.40 | 0.89 (0.67–1.33) | 0.991 (0.68–1.58) | 0.89 (0.66–1.29) |
| Readmissiona | 0.41 | 65 (19%) | 7 (12%) | 58 (21%) |
| Inpatient mortality | <0.05 | 107 (32%) | 27 (45%) | 80 (29%) |
TBSA total body surface area
Values reported as median (interquartile range) or n (%) unless otherwise stated; P values: comparing sites using Rank-sum test for continuous or chi-squared or Fisher’s exact for nominal or categorical variables
aSurvivors only
Non-survivors only: demographics and injury by sex (N = 107)
| Variable |
| Total | Female | Male |
|---|---|---|---|---|
| Age | 0.10 | 55 (40–69) | 63 (45–73) | 53 (39–66) |
| Caucasiana | 0.19 | 77/83 (93%) | 17/19 (89%) | 60/64 (94%) |
| Hispanic/Latinoa | <0.05 | 31/81 (38%) | 3/19 (16%) | 28/62 (45%) |
| Body mass index | 0.46 | 27.9 (24.0–32.4) | 27.1(22.3–32.9) | 28.0 (24.5–32.2) |
| Body surface area | <0.05 | 2.01 (1.86–2.21) | 1.87 (1.56–2.1) | 2.06(1.90–2.20) |
| At least one comorbidity | 0.06 | 67 (63%) | 21 (78%) | 46 (58%) |
| Diabetes mellitus | 0.14 | 11 (10%) | 5 (19%) | 6 (8%) |
| Current smoker | 0.40 | 21 (20%) | 7 (26%) | 14 (18%) |
| Chronic drinker | 0.15 | 19 (18%) | 2 (7%) | 17 (21%) |
| Drug addict | 0.64 | 6 (6%) | 2 (7%) | 4 (5%) |
| Hypertension requiring medication | <0.05 | 24 (22%) | 8 (30%) | 16 (20%) |
| Mental health diagnosis | 0.34 | 14 (13%) | 5 (19%) | 9 (11%) |
| % TBSA | 0.66 | 58 (36–77) | 53 (36–70) | 59 (35–82) |
| % Full thickness | 0.77 | 46 (22–70) | 46 (24–67) | 43 (21–73) |
| % Partial thickness | 0.36 | 7 (3–20) | 6 (3–13) | 8 (2–22) |
| Full thickness/TBSA ratio | 0.71 | 0.90 (0.67–0.99) | 0.92 (.75–.99) | 0.89 (.56–1.00) |
| Inhalation injury | 0.12 | 53 (50%) | 17 (63%) | 36 (45%) |
| Revised Baux | 0.17 | 122 (101–139) | 127 (117–141) | 115 (101–139) |
| Hematocrit | 0.09 | 46 (41–53) | 44 (40–48) | 47 (41–55) |
| Worst base deficit in 1st 24 h | 0.49 | −9.8 (−12.8, −6.2) | −9.4 (−12.2, −7.1) | −9.8 (−14.6, −6) |
| Worst base deficit in 2nd 24 h | 0.24 | −6.9 (−9.5, −3.9) | −6.3 (−8.5, −3.2) | −6.9 (−10.4, −3.9) |
| BUN | 0.74 | 16 (12–18) | 16 (9–18) | 16 (12–18) |
| Admission blood glucose | 0.32 | 167 (129–226) | 181 (138–235) | 164 (127–220) |
| Admit HgA1c | 0.62 | 5.8 (5.2–6.5) | 6.1 (5.2–9.9) | 5.5 (5.2–6.4) |
| Admit albumin | 0.83 | 2.8 (2.1–3.2) | 2.8 (2.2–3.2) | 2.8 (2.1–3.3) |
| SOFA in 1st 24 h | 0.99 | 8 (6–10) | 8 (6–10) | 8 (6–10) |
| SOFA in 1st 24–48 h | 0.55 | 8 (6–10) | 9 (6–11) | 8 (5–10) |
TBSA total body surface area, BUN blood urea nitrogen, SOFA sequential organ failure assessment
Values reported as median (interquartile range) or n (%) unless otherwise stated; P values: comparing sites using Rank-sum test for continuous or chi-squared or Fisher’s exact for nominal or categorical variables
aUnknown were excluded
Fig. 1Kaplan-Meier survival curve. Women trended toward earlier deaths on day 4 (IQR 2–17) vs. day 10 (IQR 2–24); however, this trend was not found to be statistically significant (P = 0.28)
Fig. 2Mortality rate by gender, 2006–2015. Figure reproduced from the National Burn Repository [38] with permission from the American Burn Association